Evidence map›Paper›PMID 42046860›Full record

ArticleBritish journal of haematology2026

Impact of CD34

Yusuke Toda, Tomoyasu Jo, Yasuyuki Arai, Kaito Harada, Masamitsu Yanada, Takahiro Fukuda, Satoshi Yoshihara, Noriko Doki, Naoyuki Uchida, Yasuo Mori and 12 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of haematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Yusuke TodaDepartment of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID https://orcid.org/0009-0001-3356-3841
Tomoyasu JoDepartment of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID https://orcid.org/0000-0001-9381-0421
Yasuyuki AraiDepartment of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID https://orcid.org/0000-0002-9662-5093
Kaito HaradaDepartment of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.
Masamitsu YanadaDepartment of Hematology and Oncology, Nagoya City University East Medical Center, Nagoya, Japan.ORCID https://orcid.org/0000-0003-1602-9775
Takahiro FukudaDepartment of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
Satoshi YoshiharaDepartment of Hematology, Hyogo Medical University Hospital, Hyogo, Japan.
Noriko DokiHematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
Naoyuki UchidaDepartment of Hematology, Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital, Tokyo, Japan.
Yasuo MoriHematology, Oncology & Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.ORCID https://orcid.org/0000-0001-6425-1720
Yuta HasegawaDepartment of Hematology, Hokkaido University Hospital, Sapporo, Japan.
Yukio KondoDepartment of Hematology, Toyama Prefectural Central Hospital, Toyama, Japan.
Toshiro KawakitaDepartment of Hematology, NHO Kumamoto Medical Center, Kumamoto, Japan.
Tetsuya EtoDepartment of Hematology, Hamanomachi Hospital, Fukuoka, Japan.
Tetsuya NishidaDepartment of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan.
Masatsugu TanakaDepartment of Hematology, Kanagawa Cancer Center, Kanagawa, Japan.
Makoto OnizukaDepartment of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.ORCID https://orcid.org/0000-0003-3864-0823
Katsuhiro ShonoDepartment of Hematology, Chiba Aoba Municipal Hospital, Chiba, Japan.
Masayuki HinoHematology, Osaka Metropolitan University, Osaka, Japan.
Tatsuo IchinoheDepartment of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
Yoshiko AtsutaJapanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan.
Takaaki KonumaDepartment of Hematology/Oncology, the Institute of Medical Science, The University of Tokyo, Tokyo, Japan.ORCID https://orcid.org/0000-0002-1953-8463

Funding

Japan Society for the Promotion of Science 24K19198
6 · The paper itself

Abstract

CD34

Indexed as

Antigens, CD34Leukemia, Myeloid, AcutePeripheral Blood Stem Cell TransplantationAdolescentAdultAgedFemaleGraft SurvivalHumansMaleMiddle AgedRetrospective StudiesSurvival RateTransplantation, HomologousTreatment OutcomeYoung AdultAntigens, CD34acute myeloid leukaemiaCD34+ cell doseperipheral blood stem cell transplantationrelated allogeneic transplantation

Identifiers

PMID42046860
PMCPMC13340483

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.